Caplight Directory>Companies>Prolevi Bio-preview>Prolevi


Prolevi Bio

Prolevi Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://prolevi.bio

Last Round

Series A

Jan 31, 2023

Total Funding Raised

$280,000

Momentum Score

25 /100

Company Overview

Prolevi Bio is a biotechnology company that develops biologic-based therapies to improve the lives of patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Subscription SaaS

AI Layer

Non-AI

Keywords

hypothyroidism treatmentthyroid hormone therapydelayed-release formulationcircadian rhythm therapypersonalized medicinedrug formulation platformchronotherapyprecision medicinedrug deliverycontrolled-release drugsmetabolic disordersclinical-stage biotechpharmaceutical licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prolevi Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Prolevi Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 31, 2023
SeedSep 14, 2022
AcceleratorJan 1, 2022
View all Funding Rounds

Prolevi Bio Investors

Notable investors and investment history

InvestorRounds
Almi Invest ABSeries A, Seed
View all Investors

Prolevi Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prolevi Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prolevi Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range6
Year Founded2020
Last FundingJan 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.